MicroBioChips is supported by OSEO-Anvar Paris.

MicroBiochips is the French biotechnology company dedicated to protein&antibody biochips services and products.
OSEO decides to support MicroBioChips development through its microorganism biochip program. MicroBioChips intends to use its expertise and know-how in protein microarray management to build an innovative microorganism microarray for infectious disease studies. Such a microarray will speed up drug discovery and prognostic in vaccine therapies.

ANVAR ("French Agency for Innovation"), is a public institution, established in 1968 to exploit the results of scientific research has been transformed into a limited company since July 2005, as part of its rapprochement with BDPME Bank (SME development), which gave birth to the OSEO group.